z-logo
open-access-imgOpen Access
Efficacy of Phage-Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates
Author(s) -
Hafiza Qurat-ul-Ain,
Muhammad Ijaz,
Abu Baker Siddique,
Saima Muzammil,
Muhammad Shafique,
Muhammad Hidayat Rasool,
Ahmad Almatroudi,
Mohsin Khurshid,
Tamoor Hamid Chaudhry,
Bilal Aslam
Publication year - 2021
Publication title -
jundishapur journal of microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.281
H-Index - 29
eISSN - 2008-4161
pISSN - 2008-3645
DOI - 10.5812/jjm.111926
Subject(s) - phage therapy , klebsiella pneumoniae , microbiology and biotechnology , antibiotics , tetracycline , antibiotic resistance , multiple drug resistance , cefepime , klebsiella , biology , virology , medicine , bacteriophage , imipenem , escherichia coli , biochemistry , gene
Background: Increasing antibiotic resistance warrants therapeutic alternatives to eradicate resistant bacteria. Combined phage-antibiotic therapy is a promising approach for eliminating bacterial infections and limiting the evolution of therapy-resistant diseases. Objectives: In the present study, we evaluated the effects of combinations of bacteriophages and antibiotics against multidrug-resistant (MDR) Klebsiella pneumoniae. Methods: Two MDR strains (GenBank no. MF953600 & MF953599) of K. pneumoniae were used. Bacteriophages were isolated from hospital sewage samples by employing a double agar overlay assay and identified by transmission electron microscopy. For further characterization of bacteriophages, the killing assay and host range test were performed. To assess therapeutic efficacy, phages (7.5 × 104 PFU/mL) were used in combination with various antibiotics. Results: The phage-cefepime and tetracycline combinations displayed promising therapeutic effects, restricting the growth of K. pneumoniae isolates, as evidenced by recording OD650nm values. Conclusions: The results of the current study showed that phage-antibiotic combination was a potential therapeutic approach to treat the infections caused by MDR K. pneumoniae.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here